Account
dentsu retains Standard Chartered global media remit
Mumbai: dentsu International has been selected as Standard Chartered’s media agency of record for a further five years. The mandate was won following a multi-agency pitch.
According to a statement, the assignment covers Standard Chartered’s global markets across media planning, strategy, and buying.
“It’s the motivation of our business, and a principle we clearly share with dentsu in the commitments and progress they’re making to be a force for good. We are committed to reducing carbon emissions, lifting participation and improving lives, and setting a new model of globalisation based on transparency, fairness and trust,” commented Standard Chartered global head of brand strategy & consumer, private and business banking marketing, Emma Sheller. “dentsu came to the table with a deep knowledge of our business, our commitments and how we can drive growth from the media with an impressive service model and a team aligned to that value set.”
“We presented Standard Chartered with a team of brilliant people, who felt passionately about delivering performance with purpose for the Standard Chartered business, which set strong foundations for us to build the next five years on,” remarked dentsu Asia Pacific & Singapore media CEO Prerna Mehrotra. “Our vision for good growth, delivered through our ‘one dentsu’ service model across the diverse markets Standard Chartered operates in, delivered the competitive advantage for the team.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
